Our People to Live Stronger & Longer

Avian Influenza (Bird Flu): What ACCHOs and Communities Need to Know

Australia is currently responding to detections of H5 avian influenza (bird flu) in wild seabirds, including two confirmed detections in New South Wales (NSW). While the current risk to people remains low, bird flu is an important reminder of the close connection between human health, animal health and the health of Country.

For Aboriginal and Torres Strait Islander peoples, bird flu is not only a public health issue. Many bird species are closely connected to Country, culture and community wellbeing, making it important that communities have access to accurate information and know how to respond safely if sick or dead birds are found.

What is avian influenza?

Avian influenza is caused by certain influenza A viruses that can infect wild birds, poultry and, more rarely, other animals and people. The strain currently circulating globally is H5N1 clade 2.3.4.4b, which has spread widely among wild birds, poultry and some mammal species since 2020. Australia was the last continent to detect this strain in June 2026.

Human infection with avian influenza remains rare and typically occurs following close contact with infected birds, other infected animals, or contaminated environments. People at increased risk include wildlife carers, rangers, hunters and others who handle sick or dead birds and wildlife. Person-to-person transmission remains extremely uncommon.

You can find out more about common signs of bird flu in animals here.

Current situation in Australia

As of 30 July 2026, Australia had recorded 28 confirmed detections of H5N1 avian influenza in wild seabirds across Western Australia, South Australia, NSW, Queensland and Victoria.

Importantly, genomic evidence has now confirmed transmission of the virus among wild birds in South Australia. Previous detections were considered isolated cases associated with infected migratory birds. While this is a significant development and may have serious impacts on wildlife, it is a scenario that health, animal and environmental agencies have been planning and preparing for over many years.

There remains no evidence of infection in Australian poultry and no evidence of other animal or human infection and the Australian Centre for Disease Control (CDC) currently assesses the risk to the Australian public as low.

In NSW, the only confirmed detections remain the two giant petrels found near Hawks Nest on the Mid North Coast. There is currently no evidence of local animal-to-animal transmission in NSW, and environmental surveillance and monitoring activities continue. Authorities remain alert to the possibility of further virus incursions through infected seabirds arriving directly on the NSW coastline or through spread from areas where local transmission is now occurring interstate.

NSW Health is working closely with animal health and environmental agencies under a One Health framework to undertake coordinated preparedness and response activities.

What does this mean for ACCHOs?

ACCHOs are trusted sources of health information and support within communities. They have an important role in sharing accurate information, promoting awareness and helping community members understand how to respond safely to sick or dead birds.

ACCHOs can also help reassure communities that the current risk to people remains low while encouraging practical measures to reduce potential exposure.

As media coverage of avian influenza is likely to increase following confirmation of transmission among wild birds in Australia, ACCHOs may receive additional questions from community members. Services can help by reinforcing that, while this development is important for wildlife health and environmental monitoring, there remains no evidence of human infection in Australia and the risk to the wider community remains low.

NSW Health has published a clinician alert on avian influenza. While most patients presenting with flu-like symptoms will have common respiratory infections, clinicians should consider avian influenza in patients with compatible symptoms and contact with unwell birds or animals within the previous 10 days.

If avian influenza is suspected, isolate the patient immediately and contact your local Public Health Unit on 1300 066 055 for advice on testing, infection control and public health follow up.

Clinicians should also strongly encourage patients to remain up to date with their seasonal influenza vaccination. Although the vaccine does not protect against avian influenza, it reduces the risk of co-infection with seasonal and avian influenza viruses and is an important measure to reduce the burden of influenza in the community.

Key messages for patients

Community members can be reassured that:

  • The current risk of H5 bird flu to people in Australia is low.
  • Bird flu does not spread easily to humans.
  • There is currently no evidence of transmission to Australian poultry.
  • Poultry meat and eggs are safe to eat when handled and cooked using standard food safety practices.

To stay safe:

  • Avoid touching sick or dead birds and other wildlife.
  • Keep pets and children away from sick or dead birds and animals
  • If you find sick or dead birds, record the location and report them
  • Wash hands thoroughly with soap and water after contact with wildlife
  • Individuals who work closely with wildlife, including rangers and wildlife carers, should always use appropriate personal protection equipment (PPE).

The national message is simple: Avoid – Record – Report.

Reports can be made to the Emergency Animal Disease Hotline on 1800 675 888.

Resources for ACCHOs and Communities

The NSW Department of Primary Industries and Regional Development has developed resources specifically for First Nations communities, including:

These resources can support community education activities and help ensure communities have access to trusted, culturally appropriate information.

Key takeaway

While the current risk of bird flu to people in Australia remains very low, ACCHOs play an important role in supporting community awareness and preparedness. Clinicians should remain alert to the possibility of avian influenza in patients with compatible symptoms and relevant bird or animal exposure history, and seek advice promptly from the Public Health Unit when cases are suspected.

Sexual Health Updates

The NSW HIV Strategy 2026-2030 was launched in May 2026. NSW ACCHOs can make an impact by maintaining the low prevalence of HIV in NSW through the key strategies: Prevent – Test – Treat – Stigma and discrimination. To support this vital work, ASHM has recently incorporated all the HIV guidelines here.

A useful tool includes the PrEP Guidelines which support GPs in prescribing PrEP for those at risk of acquiring HIV. In addition, AH&MRC provides FREE condoms and lube to all our member services so reach out to our Sexual Health Nurse Kodie kalderton@ahmrc.org.au to order now.

You’ll also notice a new look to the Australian STI Management Guidelines, making it easier to navigate while used in-consult. The site will soon have an AI-powered assistant – MIRA – which is anticipated to provide users a smoother and faster way to access clinical guidance.

The online resource Syphilis Guidance for Primary Care has also been recently updated, providing a centralised location for key information around syphilis screening and management. As a member of the Enhance Syphilis Response Program, AH&MRC remains focused on supporting our Members in reducing the burden of syphilis in NSW communities.

A reminder that the NSW Sexual Health Info Link (SHIL) has a dedicated phone service for health professionals Monday-Friday from 9am to 7pm that can support syphilis management and referral. You can contact SHIL on 1800 451 624.

For any additional sexual health support, please reach out to our Sexual Health Nurse Kodie at kalderton@ahmrc.org.au or alternatively our Public Health team at publichealth@ahmrc.org.au

New Resource – Genomics and Precision Medicine

AH&MRC continues to partner with the ALIGN team and ACCHOs across NSW to support Aboriginal leadership in genomics and precision medicine.

Community visits, workshops and ongoing engagement over the past two years, have helped shape an Aboriginal-led approach that prioritises cultural safety, Aboriginal data sovereignty and community governance when using genomics in healthcare.

As part of this work, ALIGN has released a new animated resource, Genomics Our Way: Precision Medicine Explained, which provides a clear and accessible introduction to genomics and precision medicine.

The animation was developed through the NSW Precision Medicine Initiative and reflects the perspectives and priorities shared by Aboriginal communities during the co-design process.

It explains how genomics may help deliver more personalised healthcare in the future, while highlighting the importance of Aboriginal leadership and decision-making in genomic research and healthcare programs.

This resource may be useful for:

  • Community education and engagement activities
  • Discussions about genomics and precision medicine within ACCHOs
  • Supporting workforce development and staff awareness

As genomics becomes increasingly integrated into healthcare, resources such as this can help ensure Aboriginal communities, health workers and health services are well informed and positioned to guide how these technologies are used in ways that benefit Aboriginal people.

For further information on how your service can be involved contact Folau Tabot, Senior Engagement Officer FTalbot@ahmrc.org.au or the AH&MRC Public Health Team at Publichealth@ahmrc.org.au

Protect Against Pneumococcal Disease: Free Vaccination from Age 25

Aboriginal and Torres Strait Islander adults aged 25 years and over are now eligible for a free pneumococcal vaccine under the National Immunisation Program (NIP), following important changes to the immunisation schedule introduced on 1 July 2026.

The Australian Government has updated the adult pneumococcal vaccination program with the introduction of the 21-valent pneumococcal conjugate vaccine (21vPCV), Capvaxive.

The new vaccine provides broader protection against pneumococcal disease, simplifies the adult vaccination schedule and replaces Prevenar 13 and Pneumovax 23 for adults receiving pneumococcal vaccination through the NIP.

Capvaxive is now recommended and available free of charge for:

  • Aboriginal and Torres Strait Islander adults aged 25 years and over
  • Adults aged 65 years and over
  • Adults aged 18 years and over with specified medical conditions that increase their risk of severe pneumococcal disease.

These changes lower the recommended age for routine pneumococcal vaccination for Aboriginal and Torres Strait Islander adults and expand protection against 21 strains of pneumococcal disease.

Pneumococcal vaccination continues to be recommended for:

  • All infants and children under five years of age, including Aboriginal and Torres Strait Islander children.
  • People of any age with specified medical conditions increase their risk of severe pneumococcal disease.
  • Aboriginal and Torres Strait Islander adults aged 25 years and over.
  • Adults aged 65 years and over.

Vaccination is the most effective way to reduce the risk of severe illness, hospitalisation and complications.

By getting vaccinated, you can protect yourself, your families and your communities.

The free pneumococcal vaccine is available through Aboriginal Community Controlled Health Organisations (ACCHOs), general practices (GPs), participating pharmacies and other immunisation providers.

If you are an Aboriginal or Torres Strait Islander person aged 25 years or over, speak with your local ACCHO, GP or vaccination provider to check your eligibility and ensure your pneumococcal vaccinations are up to date.

For more information:

Congenital Syphilis: New NSW Guidance for Health Services

In mid-July, NSW Health released the Guidance for Clinical Review of Congenital Syphilis and Inadequately Treated Maternal Syphilis providing a consistent framework for reviewing cases across the state. The guidance supports health services to detect contributing factors and identify ways to strengthen clinical governance aiming to improve outcomes for mothers and their infants.

Importantly, the review process focuses on identifying opportunities for improvement across the health system, rather than attributing blame to individual clinicians or services. By examining factors such as access to care, testing, treatment, communication, referral pathways and follow-up, reviews aim to support shared learning and strengthen systems that help prevent future cases.

This guidance comes at an important time, as congenital syphilis cases have increased nationally and continue to disproportionately affect Aboriginal and Torres Strait Islander babies.

Naruka, E., King, J., Miller, A., Thomas, J.R., Monaghan, R., McGregor, S. (2024). Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander peoples: Annual surveillance report 2024. The Kirby Institute UNSW Sydney. Australia

ACCHOs may be contacted by their local Public Health Unit to participate in a review following a confirmed case of congenital syphilis, or where a baby is born to a woman with untreated syphilis during pregnancy who has engaged with the service. Participation in these reviews can help identify system improvements and opportunities to strengthen prevention, screening, treatment and continuity of care for mothers and babies.

Read the guidance: Guidance for Clinical Review of Congenital Syphilis and Inadequately Treated Maternal Syphilis

For further information, contact: publichealth@ahmrc.org.au

New Resource Supports Treatment Decisions for People with Kidney Failure

The NSW Agency for Clinical Innovation (ACI) Renal Network has released a new Treatment Choices for Kidney Failure Toolkit to support people with kidney failure, their families and healthcare teams to make informed decisions about care.

Choosing a treatment for kidney failure is a significant decision that can affect a person’s health, daily life, family responsibilities and future plans. The toolkit has been developed to support clear, honest and culturally respectful conversations about available treatment options and encourages these discussions to begin early, giving people time to understand their choices and ask questions.

The resource provides easy-to-understand information about:

  • Conservative care (care without dialysis)
  • Dialysis (at home or in a dialysis centre)
  • Kidney transplant

It explains what each option involves, including potential benefits, risks and how treatment may impact day-to-day life.

Importantly, the toolkit recognises that treatment decisions are personal and should reflect an individual’s values, culture, family circumstances and goals. Aboriginal people were involved in the development of the resource to help ensure the information is culturally appropriate and relevant.

This toolkit complements other resources available to support kidney health and kidney disease care for Aboriginal and Torres Strait Islander peoples. Additional information, educational resources and support services can be accessed through Kidney Health Australia’s First Nations Australians webpage.

Find out more:

Treatment Choices for Kidney Failure Toolkit
Kidney Health Australia First Nations Australians resources